Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02266602 · ClinicalTrials.gov registry record · NA
Intraoperative Radiation Therapy in Early Stage Breast Cancer
A NA study, sponsored by Benaroya Research Institute.
- Completed
- Registry status
- NA
- Development phase
- 500
- Enrollment target
NCT02266602: Completed NA study, sponsored by Benaroya Research Institute.
NCT02266602 is a NA study that has completed, run by Benaroya Research Institute. The registered enrollment target is 500 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (64% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02266602, a NA study, has completed, sponsored by Benaroya Research Institute.
- COMPLETED
- Registry status
- NA
- Development phase
- 500 participants
- Enrollment target
Study Summary
Single arm study to assess the effectiveness of single dose intraoperative radiation therapy in patient with in situ and early stage breast cancer.
Primary Outcome
Patients are evaluated clinically at 3 months, 6 months, 9 months, 1 year and every six months for 10 years for disease recurrence. In addition to clinical exams, yearly mammograms and other imaging studies as deemed appropriate will be obtained to rule out recurrent disease. Recurrent disease will be defined as cancer recurrence within 2cm of site of original tumor bed (marked by surgical clips).
Interventions
- RADIATION Intraoperative Radiation Therapy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 500 participants |
| Start Date | 2012-02 |
| Est. Completion | 2018-07-31 |
| Phase | NA |
What the finished NCT02266602 record still lists
NCT02266602 is an interventional study that assigns participants to a tested intervention. The registered 500 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (64% lower).
The record links to 0 conditions, and to 1 intervention - of which Intraoperative Radiation Therapy is the first listed.
NCT02266602 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02266602 about?
NCT02266602 is a clinical study titled "Intraoperative Radiation Therapy in Early Stage Breast Cancer". Single arm study to assess the effectiveness of single dose intraoperative radiation therapy in patient with in situ and early stage breast cancer.
What is the current status of trial NCT02266602?
This trial is currently completed. It is a NA study. The enrollment target is 500 participants. The study started on 2012-02. Estimated completion is 2018-07-31.
What interventions are being tested in trial NCT02266602?
The interventions under investigation include: Intraoperative Radiation Therapy (RADIATION).
Who is sponsoring clinical trial NCT02266602?
This trial is sponsored by Benaroya Research Institute, which has 28 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02266602's enrollment target sits among peer trials
500 193rd of 2000 higher than 1,788 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00001230 · 500 participants
Host Response to Infection and Treatment in Filarial Diseases
- NCT00001529 · 500 participants
Improved Methods of Cell Selection for Bone Marrow Transplant Alternatives
- NCT00697411 · 500 participants
Study of Selected X-Linked Disorders: Aicardi Syndrome
- NCT00903110 · 500 participants
Global Patient Registry to Monitor Long-term Safety and Effectiveness of Increlex® in Children and Adolescents With Severe Primary Insulin-like Growth Factor-1 Deficiency (SPIGFD).
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia